MX381469B - Metodo para fabricar un dispositivo para la administracion de farmacos. - Google Patents

Metodo para fabricar un dispositivo para la administracion de farmacos.

Info

Publication number
MX381469B
MX381469B MX2018007675A MX2018007675A MX381469B MX 381469 B MX381469 B MX 381469B MX 2018007675 A MX2018007675 A MX 2018007675A MX 2018007675 A MX2018007675 A MX 2018007675A MX 381469 B MX381469 B MX 381469B
Authority
MX
Mexico
Prior art keywords
drugs
administration
manufacturing
delivery device
drug delivery
Prior art date
Application number
MX2018007675A
Other languages
English (en)
Other versions
MX2018007675A (es
Inventor
Christine Talling
Heikki Lyytikäinen
Petri Laakso
Saara Ruotsalainen
Svante Holmberg
Original Assignee
Bayer Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Oy filed Critical Bayer Oy
Publication of MX2018007675A publication Critical patent/MX2018007675A/es
Publication of MX381469B publication Critical patent/MX381469B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A61F6/142—Wirelike structures, e.g. loops, rings, spirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/14—Female reproductive, genital organs
    • A61M2210/1475—Vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Lining Or Joining Of Plastics Or The Like (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Adhesives Or Adhesive Processes (AREA)

Abstract

La invención se refiere a un método para producir un dispositivo para la administración de fármacos, el cual tiene un cuerpo que comprende un elastómero a base de siloxano y por lo menos un agente activo. El método comprende la aplicación de material adhesivo, el cual comprende elastómero a base de siloxano sin curar, en contacto con el cuerpo y curado de dicho material adhesivo sometiéndolo a energía de radiación desde una fuente láser. La invención se refiere además a un dispositivo para la administración de fármacos manufacturado de acuerdo con el método.
MX2018007675A 2015-12-21 2016-12-19 Metodo para fabricar un dispositivo para la administracion de farmacos. MX381469B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15201533 2015-12-21
PCT/EP2016/081715 WO2017108676A1 (en) 2015-12-21 2016-12-19 Method for manufacturing a drug delivery device and a drug delivery device manufactured according to the method

Publications (2)

Publication Number Publication Date
MX2018007675A MX2018007675A (es) 2018-09-12
MX381469B true MX381469B (es) 2025-03-12

Family

ID=55024876

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018007675A MX381469B (es) 2015-12-21 2016-12-19 Metodo para fabricar un dispositivo para la administracion de farmacos.

Country Status (23)

Country Link
US (1) US11007140B2 (es)
EP (1) EP3393452B1 (es)
JP (1) JP6936801B2 (es)
KR (1) KR20180103071A (es)
CN (1) CN108430453B (es)
AR (1) AR107098A1 (es)
AU (1) AU2016375432A1 (es)
BR (1) BR112018012743A2 (es)
CA (1) CA3008941C (es)
CL (1) CL2018001691A1 (es)
CO (1) CO2018006393A2 (es)
HK (1) HK1257934A1 (es)
IL (1) IL259343A (es)
JO (1) JOP20160267B1 (es)
MX (1) MX381469B (es)
MY (1) MY193641A (es)
PE (1) PE20181214A1 (es)
RU (1) RU2732822C2 (es)
SG (1) SG11201805114RA (es)
TW (1) TWI726956B (es)
UA (1) UA124382C2 (es)
UY (1) UY37043A (es)
WO (1) WO2017108676A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3687495A1 (en) * 2017-09-27 2020-08-05 Bayer Oy A method for modifying release of a therapeutically active agent from an elastomeric matrix

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
FR2618329B1 (fr) * 1987-07-22 1997-03-28 Dow Corning Sa Procede de fabrication d'un anneau capable d'assurer la liberation d'un agent therapeutique, et anneau fabrique par ce procede
US6846852B2 (en) * 2001-08-16 2005-01-25 Goldschmidt Ag Siloxane-containing compositions curable by radiation to silicone elastomers
CN1403172A (zh) * 2001-09-07 2003-03-19 上海市计划生育科学研究所 一种用于治疗妇女更年期综合症的药物控释装置
CN1264488C (zh) * 2003-05-14 2006-07-19 上海市计划生育科学研究所 阴道环简易制备方法
NZ572193A (en) * 2006-03-31 2011-10-28 Quadra Logic Tech Inc Nasolacrimal drainage system implants for drug therapy with non-fluid swellable retention structure around drug core
US20070260300A1 (en) * 2006-05-04 2007-11-08 Daniel Gregorich Intraluminal medical device having a curable coating
US8741329B2 (en) * 2007-09-21 2014-06-03 Merck Sharp & Dohme B.V. Drug delivery system
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
KR101656897B1 (ko) * 2008-10-29 2016-09-12 쓰리엠 이노베이티브 프로퍼티즈 컴파니 전자빔 경화된, 비작용화된 실리콘 감압 접착제
FI121000B (fi) * 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi
US8212934B2 (en) * 2009-02-19 2012-07-03 Sony Corporation Method for processing an analog television signal
FI20095563A7 (fi) * 2009-05-20 2010-11-21 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
IN2012DN00711A (es) * 2009-07-21 2015-06-19 Population Council Inc
DE102010003494A1 (de) * 2010-03-31 2011-10-06 Bayer Schering Pharma Aktiengesellschaft Parenterales Abgabesystem, das Aromatasehemmer und Gestagene freisetzt, für die Behandlung von Endometriose
CA2808276A1 (en) * 2010-08-20 2012-02-23 Teva Women's Health, Inc. Intravaginal devices, methods of making, and uses thereof
US20120057219A1 (en) * 2010-09-07 2012-03-08 Panasonic Corporation Laser light source apparatus
CN103747765B (zh) * 2011-06-06 2016-04-06 橡冠科学研究院 采用芯吸释放窗口的药物递送装置
JP6275123B2 (ja) * 2012-05-18 2018-02-07 スリーエム イノベイティブ プロパティズ カンパニー 医療用接着物品
JP6263548B2 (ja) * 2012-12-12 2018-01-17 スリーエム イノベイティブ プロパティズ カンパニー 室温硬化性シロキサン系ゲル
JP6657897B2 (ja) * 2015-12-10 2020-03-04 株式会社リコー ミラー部材の加工方法

Also Published As

Publication number Publication date
IL259343A (en) 2018-07-31
UA124382C2 (uk) 2021-09-08
HK1257934A1 (zh) 2019-11-01
RU2018126720A (ru) 2020-01-24
US20190000751A1 (en) 2019-01-03
CO2018006393A2 (es) 2018-07-10
EP3393452A1 (en) 2018-10-31
JP6936801B2 (ja) 2021-09-22
AU2016375432A1 (en) 2018-06-14
SG11201805114RA (en) 2018-07-30
TWI726956B (zh) 2021-05-11
CN108430453A (zh) 2018-08-21
CA3008941C (en) 2024-01-02
PE20181214A1 (es) 2018-07-24
JOP20160267B1 (ar) 2021-08-17
RU2018126720A3 (es) 2020-04-06
US11007140B2 (en) 2021-05-18
CL2018001691A1 (es) 2018-10-05
TW201726069A (zh) 2017-08-01
UY37043A (es) 2017-07-31
MY193641A (en) 2022-10-21
AR107098A1 (es) 2018-03-21
CN108430453B (zh) 2023-03-17
MX2018007675A (es) 2018-09-12
JP2019502702A (ja) 2019-01-31
EP3393452B1 (en) 2021-08-04
BR112018012743A2 (pt) 2018-12-04
WO2017108676A1 (en) 2017-06-29
CA3008941A1 (en) 2017-06-29
KR20180103071A (ko) 2018-09-18
RU2732822C2 (ru) 2020-09-22

Similar Documents

Publication Publication Date Title
NI201800038S (es) Dispositivo de administración de medicamento intranasal
CY1122716T1 (el) Ρινικη συσταση κονεως για την αγωγη της υπογλυκαιμιας
CY1124729T1 (el) Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου
CY1124033T1 (el) Δοσολογια και χορηγηση μη φουκοζυλιωμενων αντισωματων anti-cd40
CO2019009680A2 (es) Anticuerpo anti-gprc5d y molécula que comprende el anticuerpo
CU20170014A7 (es) Conjugados de fármacos con anticuerpos anti-cdh6
MX2020011371A (es) Nuevos dispositivos medicos, vehiculos de suministro y fabricacion de los mismos.
MX2017006653A (es) Metodos para modular los niveles de fármaco en plasma mediante el uso de eritrohidroxibupropión.
UY35490A (es) Conjugados de fármacos con anticuerpos
PH12018502738A1 (en) Compositions, devices, and methods for the treatment of alcohol use disorder
TW201611859A (en) Microneedle device
MX2017000141A (es) Nanoparticulas terapeuticas dirigidas y metodos para elaborar y utilizar las mismas.
NI201600070A (es) Inhibidores tetracíclicos de autotaxina
BR112018006870A2 (pt) nanopartículas terapêuticas que compreendem um agente terapêutico e métodos para a produção e o uso das mesmas
MX2020003667A (es) Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende un polimero de silicona.
BR112017002915A2 (pt) processo para manufaturar um dispositivo de uso médico customizável e dispositivo obtido pelo dito processo
CY1125031T1 (el) Μεθοδος για γενετικη θεραπεια χρησιμοποιωντας τον ιο aav-xbp1s/gfp και χρηση αυτης στην προληψη και τη θεραπεια της αμυοτροφικης πλευρικης σκληρυνσης
MX2018008196A (es) Tratamiento para cancer de mama usando una combinacion de una formulacion liposomal cationica de taxano, una formulacion no liposomal de taxano y un agente activo adicional.
MX381469B (es) Metodo para fabricar un dispositivo para la administracion de farmacos.
MX2019011847A (es) Metodo para tratar un efecto secundario de la terapia de celulas t con receptor de antigeno quimerico (car).
MX2017007567A (es) Composicion farmaceutica para el tratamiento de enfermedades gastrointestinales.
CL2022000207A1 (es) Método de fabricación de microagujas usando una composición de alta viscosidad.
AR101563A1 (es) Terapia de combinación de anticuerpos activadores de la cd40 humana y anticuerpos contra el mp-l1 humano
MX394461B (es) Ajuste de la dosis.
AR104570A1 (es) Métodos de tratamiento de una enfermedad neurodegenerativa